SLP - Simulations Plus, Inc.
IEX Last Trade
28.23
0.130 0.461%
Share volume: 560
Last Updated: Fri 27 Dec 2024 06:28:45 PM CET
Data Processing, Hosting, and Related Services:
14.60%
PREVIOUS CLOSE
CHG
CHG%
$28.10
0.13
0.46%
Fundamental analysis
44%
Profitability
35%
Dept financing
25%
Liquidity
75%
Performance
50%
Performance
5 Days
0.07%
1 Month
-10.62%
3 Months
-8.75%
6 Months
-40.57%
1 Year
-37.98%
2 Year
-25.61%
Key data
Stock price
$28.23
DAY RANGE
$28.06 - $28.88
52 WEEK RANGE
$27.72 - $51.22
52 WEEK CHANGE
-$37.90
DIVIDEND
$0.06
EX-DIVIDEND DATE
07/29/2024
NEXT EARNINGS DATE
10/23/2024
Company detail
CEO: Shawn M. O'Connor
Region: US
Website: simulations-plus.com
Employees: 160
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information
Region: US
Website: simulations-plus.com
Employees: 160
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym; IPFsym; RENAsym; MITOsym.
Recent news